North Star Investment Management’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $485 | Hold |
60
| – | – | ﹤0.01% | 1160 |
|
|
2025
Q1 | $503 | Hold |
60
| – | – | ﹤0.01% | 1144 |
|
|
2024
Q4 | $475 | Hold |
60
| – | – | ﹤0.01% | 1172 |
|
|
2024
Q3 | $499 | Hold |
60
| – | – | ﹤0.01% | 1132 |
|
|
2024
Q2 | $381 | Hold |
60
| – | – | ﹤0.01% | 1114 |
|
|
2024
Q1 | $364 | Hold |
60
| – | – | ﹤0.01% | 1186 |
|
|
2023
Q4 | $364 | Hold |
60
| – | – | ﹤0.01% | 1148 |
|
|
2023
Q3 | $253 | Hold |
60
| – | – | ﹤0.01% | 1236 |
|
|
2023
Q2 | $186 | Hold |
60
| – | – | ﹤0.01% | 1253 |
|
|
2023
Q1 | $83 | Hold |
60
| – | – | ﹤0.01% | 1284 |
|
|
2022
Q4 | $119 | Hold |
60
| – | – | ﹤0.01% | 1289 |
|
|
2022
Q3 | $0 | Hold |
60
| – | – | ﹤0.01% | 1131 |
|
|
2022
Q2 | $0 | Hold |
60
| – | – | ﹤0.01% | 1131 |
|
|
2022
Q1 | $0 | Hold |
60
| – | – | ﹤0.01% | 1145 |
|
|
2021
Q4 | $0 | Sell |
60
-300
| -83% | – | ﹤0.01% | 1173 |
|
|
2021
Q3 | $2K | Buy |
360
+300
| +500% | +$1.67K | ﹤0.01% | 1022 |
|
|
2021
Q2 | $0 | Hold |
60
| – | – | ﹤0.01% | 1093 |
|
|
2021
Q1 | $0 | Hold |
60
| – | – | ﹤0.01% | 1053 |
|
|
2020
Q4 | $0 | Hold |
60
| – | – | ﹤0.01% | 1020 |
|
|
2020
Q3 | $0 | Hold |
60
| – | – | ﹤0.01% | 1000 |
|
|
2020
Q2 | $0 | Hold |
60
| – | – | ﹤0.01% | 971 |
|
|
2020
Q1 | $0 | Hold |
60
| – | – | ﹤0.01% | 995 |
|
|
2019
Q4 | $0 | Hold |
60
| – | – | ﹤0.01% | 1038 |
|
|
2019
Q3 | $0 | Buy |
+60
| New | – | ﹤0.01% | 1088 |
|